Ghasaq Saleh

Ghasaq Saleh

Auto-generated profile, based on publicly available information

Ghasaq Saleh

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Case Reports in Pediatrics
Verified
Journal Article
Open access
PDF file
RARaed Al-Taher
Raed Al-Taher
AAAbdallah Alabadla
Abdallah Alabadla
SASalameh Al-Halaseh
Salameh Al-Halaseh
GSGhasaq Saleh
Ghasaq Saleh
Intussusception is the invagination of a proximal bowel segment into a distal segment causing bowel obstruction, especially in children. In some cases, it can be caused by a pathological lead point, such as Burkitt lymphoma. Burkitt lymphoma has several patterns of clinical presentations, such as jaw or facial bone tumor in the endemic form, in contrast to an abdominal presentation most often with massive disease and ascites. We describe a case of a 4‐year‐old male who presented bowel obstruction. Using X‐ray and ultrasound findings, ileocecal intussusception was then diagnosed. Resection and anastomosis was performed after multiple trials of failed hydrostatic reduction. On the pathology report of the resected segment, Burkitt lymphoma was found to be the cause and chemotherapy was initiated. The patient is doing well and is following up every 6 months for 2 years. A pathological lead point, especially Burkitt lymphoma, should be suspected in patients with failed conservative treatment, and prompt diagnosis of the pathology should be performed to prevent further sequela of the disease.

23 August 2024 in JACC: Advances
Verified
Journal Article
Open access
GSGhasaq Saleh
Ghasaq Saleh
ASAgata Sularz
Agata Sularz
CLChia-Hao Liu
Chia-Hao Liu
GRGerardo V. Lo Russo
Gerardo V. Lo Russo
MAMahmoud Zhour Adi
Mahmoud Zhour Adi
MAMohamad Alkhouli
Mohamad Alkhouli

15 October 2025 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
AAAbdullah Al-Abcha
Abdullah Al-Abcha
GSGhasaq Saleh
Ghasaq Saleh
HSHanna Sledge
Hanna Sledge
MAMuhannad Abbasi
Muhannad Abbasi
MIMahmoud Ismayl
Mahmoud Ismayl
MAMohamad Alkhouli
Mohamad Alkhouli

1 October 2025 in JACC: Case Reports
Verified
Journal Article
Open access
FAFadi W. Adel
Fadi W. Adel
GSGhasaq Saleh
Ghasaq Saleh
NANandan S. Anavekar
Nandan S. Anavekar
SHSharonne N. Hayes
Sharonne N. Hayes
Immune checkpoint inhibitors (ICIs) are increasingly used in cancer therapy, but they may cause immune-related adverse events, including myocarditis, a rare but potentially fatal complication. A 74-year-old man with lung adenocarcinoma treated with durvalumab presented with acute-on-chronic hypoxemic respiratory failure and hypotension. He was recently diagnosed with ICI pneumonitis and was taking corticosteroids. Evaluation revealed elevated troponins, new T-wave inversions, and reduced left ventricular ejection fraction. Coronary angiography showed no obstructive disease. Cardiac magnetic resonance revealed diffuse myocardial edema with nonischemic late gadolinium enhancement. Endomyocardial biopsy confirmed lymphohistiocytic infiltrates consistent with ICI myocarditis. ICI-associated myocarditis can mimic acute coronary syndrome or stress cardiomyopathy. Cardiac magnetic resonance and biopsy are essential for accurate diagnosis. Early recognition and initiation of high-dose corticosteroids are critical for improved outcomes. ICI myocarditis should be considered in patients with prior ICI exposure and new cardiomyopathy. Multimodal imaging and biopsy are key to timely diagnosis and management.

5 August 2025 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
GSGhasaq Saleh
Ghasaq Saleh
AAAbdullah Al-Abcha
Abdullah Al-Abcha
KCKaram Chaaban
Karam Chaaban
MAMahmoud Zhour Adi
Mahmoud Zhour Adi
MTMarysia Tweet
Marysia Tweet
RGRajiv Gulati
Rajiv Gulati

27 August 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
GSGhasaq Saleh
Ghasaq Saleh
OEOmar Abou Ezzeddine
Omar Abou Ezzeddine
FAFadi Adel
Fadi Adel
Background: Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded amyloid fibrils within the myocardium, resulting in progressive ventricular wall thickening and heart failure. Transthyretin (ATTR) and immunoglobulin light-chain (AL) amyloidosis account for ∼95% of cases. Despite advances in diagnostic imaging and laboratory testing, CA remains underrecognized, often leading to misdiagnosis or delayed diagnosis. Timely and accurate diagnosis, including amyloid subtyping, is critical to guide appropriate therapy and improve clinical outcomes, as prognosis and management vary substantially among amyloid subtypes. Case summary: We present a three-case series illustrating distinct diagnostic and clinical challenges in CA, including a false-positive diagnosis of ATTR cardiomyopathy (ATTR-CM) based on planar technetium-99m pyrophosphate (PYP) scintigraphy that was subsequently ruled out by single-photon emission computed tomography (SPECT) imaging and further evaluation, a delayed diagnosis of AL amyloidosis in a patient with progressive heart failure initially attributed to non-ischaemic cardiomyopathy, and recurrent left atrial appendage thrombus despite therapeutic anticoagulation in a patient with AL amyloidosis. Discussion: These three cases demonstrate the broad spectrum of diagnostic and clinical challenges encountered in CA. The first case underscores the importance of SPECT imaging in differentiating true myocardial radiotracer uptake from blood pool activity, a common source of false-positive planar PYP studies. The second emphasizes the critical role of comprehensive monoclonal protein screening in patients with suspected amyloidosis as delayed diagnosis of AL amyloidosis may adversely affect outcomes. The third illustrates the heightened thromboembolic risk associated with CA, even in the setting of therapeutic anticoagulation, and supports consideration of transoesophageal echocardiography before cardioversion in this high-risk population.